OTCPK:CRTHF (China)
Â
Ordinary Shares
$
0.76
+0.0135 (+1.81%)
11:09 PM EST
Business Description
CARsgen Therapeutics Holdings Ltd
ISIN : KYG1996C1006
Share Class Description:
CRTHF: Ordinary SharesCompare
Compare
Traded in other countries / regions
02171.Hong KongCRTHF.USA IPO Date
2022-02-18Description
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.71 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.3 | |||||
3-Year EPS without NRI Growth Rate | -27.3 | |||||
3-Year FCF Growth Rate | -11.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 6.3 | |||||
9-Day RSI | 3.33 | |||||
14-Day RSI | 2.47 | |||||
6-1 Month Momentum % | -43.11 | |||||
12-1 Month Momentum % | -48.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.55 | |||||
Quick Ratio | 9.54 | |||||
Cash Ratio | 9.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 6.14 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -34.34 | |||||
ROA % | -29.05 | |||||
ROIC % | -128.05 | |||||
ROC (Joel Greenblatt) % | -183.61 | |||||
ROCE % | -31.75 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.28 | |||||
Price-to-Tangible-Book | 1.29 | |||||
EV-to-EBIT | -0.76 | |||||
EV-to-EBITDA | -0.78 | |||||
EV-to-FCF | -1.22 | |||||
Price-to-Net-Current-Asset-Value | 1.62 | |||||
Price-to-Net-Cash | 1.65 | |||||
Earnings Yield (Greenblatt) % | -131.58 | |||||
FCF Yield % | -20.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CRTHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CARsgen Therapeutics Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.187 | ||
Beta | 0 | ||
Volatility % | 54.52 | ||
14-Day RSI | 2.47 | ||
14-Day ATR ($) | 0.016035 | ||
20-Day SMA ($) | 0.795975 | ||
12-1 Month Momentum % | -48.92 | ||
52-Week Range ($) | 0.7465 - 1.86 | ||
Shares Outstanding (Mil) | 571.52 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CARsgen Therapeutics Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CARsgen Therapeutics Holdings Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
CARsgen Therapeutics Holdings Ltd Frequently Asked Questions
What is CARsgen Therapeutics Holdings Ltd(CRTHF)'s stock price today?
The current price of CRTHF is $0.76. The 52 week high of CRTHF is $1.86 and 52 week low is $0.75.
When is next earnings date of CARsgen Therapeutics Holdings Ltd(CRTHF)?
The next earnings date of CARsgen Therapeutics Holdings Ltd(CRTHF) is 2024-09-19 Est..
Does CARsgen Therapeutics Holdings Ltd(CRTHF) pay dividends? If so, how much?
CARsgen Therapeutics Holdings Ltd(CRTHF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |